CA Stock MarketDetailed Quotes

InnoCan Pharma Corp (INNO)

Watchlist
  • 5.760
  • 0.0000.00%
15min DelayMarket Closed Apr 30 10:02 ET
25.91MMarket Cap-16.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InnoCan Pharma Corp (INNO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-9.60%26.61M
-7.65%4.99M
-20.90%6.82M
-18.95%7.01M
15.19%7.8M
115.55%29.44M
10.38%5.4M
111.22%8.62M
176.96%8.64M
333.85%6.77M
Operating revenue
-9.60%26.61M
-7.65%4.99M
-20.90%6.82M
-18.95%7.01M
15.19%7.8M
115.55%29.44M
10.38%5.4M
111.22%8.62M
176.96%8.64M
333.85%6.77M
Cost of revenue
-17.51%2.68M
-43.75%558K
-25.33%631K
25.54%811K
-11.21%681K
93.57%3.25M
64.24%992K
101.67%845K
38.92%646K
303.68%767K
Gross profit
-8.61%23.93M
0.48%4.43M
-20.41%6.19M
-22.54%6.2M
18.56%7.12M
118.63%26.19M
2.80%4.41M
112.31%7.78M
201.13%8M
338.03%6M
Operating expense
-8.19%25.19M
0.45%5.35M
-0.24%7.41M
-22.32%5.8M
-8.14%6.63M
73.84%27.43M
2.80%5.33M
52.51%7.43M
141.43%7.47M
173.63%7.21M
Selling and administrative expenses
-6.30%24.25M
3.72%5.19M
-0.79%6.99M
-20.13%5.62M
-5.05%6.45M
85.09%25.89M
6.97%5.01M
58.82%7.05M
148.32%7.04M
234.10%6.79M
-Selling and marketing expense
-4.57%20.17M
12.07%4.59M
-17.05%5.06M
-18.16%4.87M
13.24%5.65M
101.85%21.13M
7.49%4.09M
88.52%6.1M
168.15%5.95M
313.16%4.99M
-General and administrative expense
-13.99%4.09M
-33.73%605K
102.93%1.94M
-30.91%751K
-55.84%794K
35.18%4.75M
4.70%913K
-20.81%955K
76.75%1.09M
118.20%1.8M
Research and development costs
-39.83%932K
-50.15%161K
10.08%415K
-58.59%176K
-57.55%180K
-13.75%1.55M
-35.91%323K
-12.53%377K
65.37%425K
-29.80%424K
Operating profit
-0.64%-1.26M
-0.33%-922K
-446.02%-1.22M
-25.70%396K
140.35%489K
67.21%-1.25M
-2.80%-919K
129.19%352K
222.25%533K
4.27%-1.21M
Net non-operating interest income (expenses)
57.14%-3K
25.00%-3K
800.00%7K
-233.33%-4K
40.00%-3K
-130.43%-7K
-126.67%-4K
66.67%-1K
50.00%3K
-155.56%-5K
Non-operating interest income
----
----
--7K
----
----
--0
--0
--0
0.00%3K
--0
Non-operating interest expense
-57.14%3K
-25.00%3K
----
--4K
-40.00%3K
--7K
300.00%4K
-66.67%1K
----
400.00%5K
Other net income (expenses)
-38.20%1.34M
171.92%2.52M
-162.96%-221K
-155.73%-501K
-15,000.00%-453K
955.51%2.17M
211.78%926K
156.80%351K
2,265.79%899K
-110.34%-3K
Gain on sale of security
-38.20%1.34M
171.92%2.52M
-162.96%-221K
-155.73%-501K
-15,000.00%-453K
955.51%2.17M
211.78%926K
156.80%351K
2,265.79%899K
-110.34%-3K
Income before tax
-90.75%85K
53,000.00%1.59M
-303.99%-1.43M
-107.60%-109K
102.70%33K
122.78%919K
100.52%3K
138.42%702K
462.12%1.43M
0.65%-1.22M
Income tax
-63.93%426K
-613.73%-262K
-47.37%220K
-56.90%206K
11.97%262K
451.87%1.18M
-76.17%51K
418K
478K
234K
Earnings from equity interest net of tax
Net income
-30.15%-341K
3,964.58%1.86M
-681.69%-1.65M
-132.95%-315K
84.25%-229K
93.83%-262K
93.97%-48K
115.54%284K
341.41%956K
-18.40%-1.45M
Net income continuous operations
-30.15%-341K
3,964.58%1.86M
-681.69%-1.65M
-132.95%-315K
84.25%-229K
93.83%-262K
93.97%-48K
115.54%284K
341.41%956K
-18.40%-1.45M
Noncontrolling interests
-50.19%783K
-312.12%-140K
-48.61%295K
-55.57%275K
12.78%353K
247.79%1.57M
-24.14%66K
187.00%574K
399.19%619K
645.24%313K
Net income attributable to the company
38.71%-1.12M
1,850.00%2M
-571.38%-1.95M
-275.07%-590K
67.06%-582K
60.98%-1.83M
87.09%-114K
85.69%-290K
164.81%337K
-39.13%-1.77M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
38.71%-1.12M
1,850.00%2M
-571.38%-1.95M
-275.07%-590K
67.06%-582K
60.98%-1.83M
87.09%-114K
85.69%-290K
164.81%337K
-39.13%-1.77M
Diluted earnings per share
61.54%-0.25
223.08%0.32
-447.69%-0.356
-300.00%-0.13
60.00%-0.13
50.00%-0.65
33.33%-0.26
85.71%-0.065
150.00%0.065
0.00%-0.325
Basic earnings per share
61.54%-0.25
223.08%0.32
-447.69%-0.356
-300.00%-0.13
60.00%-0.13
50.00%-0.65
33.33%-0.26
85.71%-0.065
150.00%0.065
0.00%-0.325
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -9.60%26.61M-7.65%4.99M-20.90%6.82M-18.95%7.01M15.19%7.8M115.55%29.44M10.38%5.4M111.22%8.62M176.96%8.64M333.85%6.77M
Operating revenue -9.60%26.61M-7.65%4.99M-20.90%6.82M-18.95%7.01M15.19%7.8M115.55%29.44M10.38%5.4M111.22%8.62M176.96%8.64M333.85%6.77M
Cost of revenue -17.51%2.68M-43.75%558K-25.33%631K25.54%811K-11.21%681K93.57%3.25M64.24%992K101.67%845K38.92%646K303.68%767K
Gross profit -8.61%23.93M0.48%4.43M-20.41%6.19M-22.54%6.2M18.56%7.12M118.63%26.19M2.80%4.41M112.31%7.78M201.13%8M338.03%6M
Operating expense -8.19%25.19M0.45%5.35M-0.24%7.41M-22.32%5.8M-8.14%6.63M73.84%27.43M2.80%5.33M52.51%7.43M141.43%7.47M173.63%7.21M
Selling and administrative expenses -6.30%24.25M3.72%5.19M-0.79%6.99M-20.13%5.62M-5.05%6.45M85.09%25.89M6.97%5.01M58.82%7.05M148.32%7.04M234.10%6.79M
-Selling and marketing expense -4.57%20.17M12.07%4.59M-17.05%5.06M-18.16%4.87M13.24%5.65M101.85%21.13M7.49%4.09M88.52%6.1M168.15%5.95M313.16%4.99M
-General and administrative expense -13.99%4.09M-33.73%605K102.93%1.94M-30.91%751K-55.84%794K35.18%4.75M4.70%913K-20.81%955K76.75%1.09M118.20%1.8M
Research and development costs -39.83%932K-50.15%161K10.08%415K-58.59%176K-57.55%180K-13.75%1.55M-35.91%323K-12.53%377K65.37%425K-29.80%424K
Operating profit -0.64%-1.26M-0.33%-922K-446.02%-1.22M-25.70%396K140.35%489K67.21%-1.25M-2.80%-919K129.19%352K222.25%533K4.27%-1.21M
Net non-operating interest income (expenses) 57.14%-3K25.00%-3K800.00%7K-233.33%-4K40.00%-3K-130.43%-7K-126.67%-4K66.67%-1K50.00%3K-155.56%-5K
Non-operating interest income ----------7K----------0--0--00.00%3K--0
Non-operating interest expense -57.14%3K-25.00%3K------4K-40.00%3K--7K300.00%4K-66.67%1K----400.00%5K
Other net income (expenses) -38.20%1.34M171.92%2.52M-162.96%-221K-155.73%-501K-15,000.00%-453K955.51%2.17M211.78%926K156.80%351K2,265.79%899K-110.34%-3K
Gain on sale of security -38.20%1.34M171.92%2.52M-162.96%-221K-155.73%-501K-15,000.00%-453K955.51%2.17M211.78%926K156.80%351K2,265.79%899K-110.34%-3K
Income before tax -90.75%85K53,000.00%1.59M-303.99%-1.43M-107.60%-109K102.70%33K122.78%919K100.52%3K138.42%702K462.12%1.43M0.65%-1.22M
Income tax -63.93%426K-613.73%-262K-47.37%220K-56.90%206K11.97%262K451.87%1.18M-76.17%51K418K478K234K
Earnings from equity interest net of tax
Net income -30.15%-341K3,964.58%1.86M-681.69%-1.65M-132.95%-315K84.25%-229K93.83%-262K93.97%-48K115.54%284K341.41%956K-18.40%-1.45M
Net income continuous operations -30.15%-341K3,964.58%1.86M-681.69%-1.65M-132.95%-315K84.25%-229K93.83%-262K93.97%-48K115.54%284K341.41%956K-18.40%-1.45M
Noncontrolling interests -50.19%783K-312.12%-140K-48.61%295K-55.57%275K12.78%353K247.79%1.57M-24.14%66K187.00%574K399.19%619K645.24%313K
Net income attributable to the company 38.71%-1.12M1,850.00%2M-571.38%-1.95M-275.07%-590K67.06%-582K60.98%-1.83M87.09%-114K85.69%-290K164.81%337K-39.13%-1.77M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 38.71%-1.12M1,850.00%2M-571.38%-1.95M-275.07%-590K67.06%-582K60.98%-1.83M87.09%-114K85.69%-290K164.81%337K-39.13%-1.77M
Diluted earnings per share 61.54%-0.25223.08%0.32-447.69%-0.356-300.00%-0.1360.00%-0.1350.00%-0.6533.33%-0.2685.71%-0.065150.00%0.0650.00%-0.325
Basic earnings per share 61.54%-0.25223.08%0.32-447.69%-0.356-300.00%-0.1360.00%-0.1350.00%-0.6533.33%-0.2685.71%-0.065150.00%0.0650.00%-0.325
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -